₹612.00-2.25 (-0.37%)
04:01 PM, 24-Dec-2025₹612.40-2.40 (-0.39%)
03:49 PM, 24-Dec-2025BSE : 532482
NSE : GRANULES
Sector : Health care
ISIN Code : INE101D01020
Last Updated: 24-Dec-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 14,853 |
Traded Value (₹ Cr) | 8.10 |
Volume (Shares) | 1,32,329 |
Face Value (₹) | 1 |
52-Week High (₹) | 626.85 |
52-Week High Date | 24-Dec-2025 |
52-Week Low (₹) | 412.05 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 724.55 |
All Time High Date | 02-Sep-2024 |
All Time Low (₹) | 1.58 |
All Time Low Date | 19-Dec-2002 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 14,863 |
| EPS - TTM (₹) [C] | 21.13 |
| P/E Ratio (X) [C] | 28.98 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 150.00 |
| Latest Dividend Date | 31-Jul-2025 |
| Dividend Yield (%) | 0.24 |
| Book Value Share (₹) [C] | 164.12 |
| P/B Ratio (₹) [C] | 3.73 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Aditya Birla SL Value Fund (G) | 135.76 | 24,41,258 | 2.13 |
| Aditya Birla SL Value Fund (IDCW) | 135.76 | 24,41,258 | 2.13 |
| Aditya Birla SL Value Fund - Direct (G) | 135.76 | 24,41,258 | 2.13 |
| Aditya Birla SL Value Fund - Direct (IDCW) | 135.76 | 24,41,258 | 2.13 |
| Edelweiss Balanced Advantage Fund (G) | 122.88 | 22,09,668 | 0.92 |
| Edelweiss Balanced Advantage Fund (IDCW-Q) | 122.88 | 22,09,668 | 0.92 |
| Edelweiss Balanced Advantage Fund - Dir (G) | 122.88 | 22,09,668 | 0.92 |
| Edelweiss Balanced Advantage Fund - Dir (IDCW-Q) | 122.88 | 22,09,668 | 0.92 |
| Edelweiss Balanced Advantage Fund (IDCW-M) | 122.88 | 22,09,668 | 0.92 |
| Edelweiss Balanced Advantage Fund - Dir (IDCW-M) | 122.88 | 22,09,668 | 0.92 |
Load more
| Today's Low/High (₹) | 610.15 624.70 |
| Week Low/High (₹) | 567.75 624.70 |
| Month Low/High (₹) | 529.85 624.70 |
| Year Low/High (₹) | 422.00 624.70 |
| All time Low/High (₹) | 1.58 721.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 5.62% | 5.64% | 1.00% | 1.25% |
| 1 Month | 14.98% | 14.93% | 0.60% | 0.70% |
| 3 Month | 15.36% | 15.37% | 4.52% | 4.33% |
| 6 Month | 25.15% | 25.18% | 4.09% | 4.38% |
| 1 Year | 2.64% | 2.61% | 8.84% | 10.18% |
| 3 Year | 87.22% | 86.51% | 42.72% | 46.81% |
CMD & Executive Director : C Krishna Prasad
Non Independent Executive Director / Joint MD : KANDIRAJU VENKATA SITARAMRAO
ED (Non-Independent) : Uma Devi Chigurupati
ED (Non-Independent) : Harsha Chigurupati
NIED /Head /Promoter : PRIYANKA CHIGURUPATI
Non-Exec & Non-Independent Dir : K B Sankara Rao
Independent Non Exe. Director : Arun Sawhney
Independent Non Exe. Director : Saumen Chakraborty
Independent Non Exe. Director : Sucharita Rao Palepu
Independent Non Exe. Director : Kapil Mehan
Independent Non Exe. Director : S Ravi
Independent Non Exe. Director : Rajiv Kakodkar
Company Sec. & Compli. Officer : Chaitanya Tummala
Registered Office: 15th Floor Granules Tower, Botanical Garden Road Kondapur,Hyderabad,Telangana-500084 Ph: 91-40-69043500
1. What's the Granules India Ltd share price today?
Granules India Ltd share price was Rs 612.00 at 04:01 PM IST on 24th Dec 2025. Granules India Ltd share price was down by 0.37% from the previous closing price of Rs 614.25. Granules India Ltd share price trend:
2. How can I quickly analyse the performance of the Granules India Ltd stock?
The performance of the Granules India Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Granules India Ltd?
Granules India Ltd has a market capitalisation of Rs 14,853 crore.
4. What is Granules India Ltd's 52-week high/low share price?
The Granules India Ltd’s 52-week high share price is Rs 626.85 and 52-week low share price is Rs 412.05.
5. Is the Granules India Ltd profitable?
On a consolidated basis, Granules India Ltd reported a profit of Rs 130.61 crore on a total income of Rs 1,295.84 crore for the quarter ended 2025.
6. Which are Granules India Ltd’s peers in the Health care sector?
Granules India Ltd’s top 5 peers in the Health care sector are Alembic Pharma, Natco Pharma, Caplin Point Lab, Granules India, Concord Biotech, Acutaas Chemical, Rubicon Research.
7. Who owns how much in Granules India Ltd?
Key changes to the Granules India Ltd shareholding are as follows: